PancakeSwap reported a significant increase in trading activity for two tokenized-stock pairs, TSLAB-USDT and NVDAB-USDT. These pairs now represent more than 41% of the total volume in PancakeSwap's bStocks market, highlighting growing investor interest in tokenized stock trading. This trend may indicate a shift towards more digital asset-based stock trading platforms in the future.
PancakeSwap's reported trading volume share in bStocks is provided here as market context. For readers following cryptocurrency markets on Pluang, as of Oct 19, 2026 14:01 WIB, 36 of 50 major cryptocurrencies rose while 13 fell. Notable movers include SOL (Solana) at Rp1.905.764 with a 2.55% increase and a typical hold time of 71 days, CAKE (PancakeSwap) at Rp39.865 up 2.41% with 87% sell order activity and a 75-day hold time, and ENJ (Enjin Coin) at Rp490 down 2.36% with 95% sell order activity and a 105-day hold time. The highest sell order activity is 95% for ENJ (Enjin Coin).
Jyske Bank has repurchased shares valued at approximately DKK 2.15 billion as part of its ongoing share buyback program running from February 2026 to January 2027. The bank has acquired a total of 2,235,959 treasury shares, representing 3.84% of its ...
Jyske Bank is conducting a share buyback program from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-October 2026, the bank has repurchased shares worth approximately DKK 2.15 billion at an average price of DK...
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
